Example: Heart Attack

Clinical Trials on HIV Wasting Syndrome

Total 20 results

NCT00002157

Completed

Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome

Conditions: HIV Infections; HIV Wasting Syndrome
NCT00002127

Completed

A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome

Conditions: HIV Infections; HIV Wasting Syndrome
NCT00006167

Completed

Nutrition Intervention in AIDS Wasting

Conditions: HIV Wasting Syndrome
NCT00000737

Completed

A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome

Conditions: Cachexia; HIV Infections; HIV Wasting Syndrome
NCT00000925

Completed

A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

Conditions: HIV Infections; HIV Wasting Syndrome
NCT00489528

Completed

Growth Hormone in the Treatment of HIV-Associated Wasting

Conditions: HIV Infections; HIV Wasting Syndrome
NCT00001079

Completed

A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

Conditions: HIV Infections; HIV Wasting Syndrome
NCT00000854

Completed

A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss

Conditions: HIV Infections; HIV Wasting Syndrome
NCT00001077

Completed

A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements

Conditions: HIV Infections; HIV Wasting Syndrome
NCT00006158

Completed

AIDS Wasting in Women: Anabolic Effects of Testosterone

Conditions: AIDS Wasting Syndrome
NCT00006064

Completed

The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children

Conditions: HIV Infections; HIV Wasting Syndrome; Lipodystrophy
NCT00004664

Completed

Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting

Conditions: Acquired Immunodeficiency Syndrome; HIV Wasting Syndrome; HIV Infections
NCT00637572

Completed

Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss

Conditions: HIV Infections; Cachexia; Anorexia; AIDS Wasting Syndrome; HIV Wasting Syndrome
NCT00028314

Completed

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

Conditions: HIV Infections; Lipodystrophy; Wasting Disease
NCT00004400

Completed

Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women

Conditions: HIV Infections; Cachexia
NCT00002345

Completed

The Safety and Effectiveness of Megace in HIV-Infected Women

Conditions: Anorexia; Cachexia; HIV Infections
NCT00002067

Completed

A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia

Conditions: Anorexia; Cachexia; HIV Infections
NCT00002300

Completed

A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition

Conditions: Anorexia; Cachexia; HIV Infections
NCT01647841

Completed

Maternal Determinants of HIV-exposed and HIV-unexposed Fetal Growth, Birth Outcomes and Early Infant Growth

Conditions: HIV; Pregnancy; Malnutrition; Cachexia
NCT00687050

Completed

Peroral Supplemental Nutrition in End-stage Renal Disease With and Without HIV Comorbidity

Conditions: End-Stage Renal Disease